Total: £ 56.28
Published Date: 2024-12-04 | Pages: 135 | Tables: 259 | Pharma & Healthcare
The global market for Meropenem Powder was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
North American market for Meropenem Powder was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Meropenem Powder was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Europe market for Meropenem Powder was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global key companies of Meropenem Powder include Pfizer, AuroMedics, Sandoz, Amneal Pharmaceuticals, Sumitomo Dainippon Pharma, Ranbaxy Laboratories, Mylan, Sagent Pharmaceuticals and Macleods Pharmaceuticals, etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Meropenem Powder, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Meropenem Powder by region & country, by Type, and by Application.
The Meropenem Powder market size, estimations, and forecasts are provided in terms of sales volume (Ton) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Meropenem Powder.
Market Segmentation
By Company
Pfizer
AuroMedics
Sandoz
Amneal Pharmaceuticals
Sumitomo Dainippon Pharma
Ranbaxy Laboratories
Mylan
Sagent Pharmaceuticals
Macleods Pharmaceuticals
Shenzhen Haibin Pharmaceutical
Chongqing Tiandi Pharmaceutical
PKU HealthCare
United Laboratories
CSPC Group
Zhejiang Hisun Pharmaceutical
Luoxin Pharmaceutical
Segment by Type:
Purity Greater than or Equal to 98%
Purity Greater than or Equal to 99%
Segment by Application
Skin Infection
Bacterial Meningitis
Pneumonia
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Meropenem Powder manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Meropenem Powder in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Meropenem Powder in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Market Overview
1.1 Meropenem Powder Product Introduction
1.2 Global Meropenem Powder Market Size Forecast
1.2.1 Global Meropenem Powder Sales Value (2019-2030)
1.2.2 Global Meropenem Powder Sales Volume (2019-2030)
1.2.3 Global Meropenem Powder Sales Price (2019-2030)
1.3 Meropenem Powder Market Trends & Drivers
1.3.1 Meropenem Powder Industry Trends
1.3.2 Meropenem Powder Market Drivers & Opportunity
1.3.3 Meropenem Powder Market Challenges
1.3.4 Meropenem Powder Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Meropenem Powder Players Revenue Ranking (2023)
2.2 Global Meropenem Powder Revenue by Company (2019-2024)
2.3 Global Meropenem Powder Players Sales Volume Ranking (2023)
2.4 Global Meropenem Powder Sales Volume by Company Players (2019-2024)
2.5 Global Meropenem Powder Average Price by Company (2019-2024)
2.6 Key Manufacturers Meropenem Powder Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Meropenem Powder Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Meropenem Powder
2.9 Meropenem Powder Market Competitive Analysis
2.9.1 Meropenem Powder Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Meropenem Powder Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Meropenem Powder as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Purity Greater than or Equal to 98%
3.1.2 Purity Greater than or Equal to 99%
3.2 Global Meropenem Powder Sales Value by Type
3.2.1 Global Meropenem Powder Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Meropenem Powder Sales Value, by Type (2019-2030)
3.2.3 Global Meropenem Powder Sales Value, by Type (%) (2019-2030)
3.3 Global Meropenem Powder Sales Volume by Type
3.3.1 Global Meropenem Powder Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Meropenem Powder Sales Volume, by Type (2019-2030)
3.3.3 Global Meropenem Powder Sales Volume, by Type (%) (2019-2030)
3.4 Global Meropenem Powder Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Skin Infection
4.1.2 Bacterial Meningitis
4.1.3 Pneumonia
4.1.4 Others
4.2 Global Meropenem Powder Sales Value by Application
4.2.1 Global Meropenem Powder Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Meropenem Powder Sales Value, by Application (2019-2030)
4.2.3 Global Meropenem Powder Sales Value, by Application (%) (2019-2030)
4.3 Global Meropenem Powder Sales Volume by Application
4.3.1 Global Meropenem Powder Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Meropenem Powder Sales Volume, by Application (2019-2030)
4.3.3 Global Meropenem Powder Sales Volume, by Application (%) (2019-2030)
4.4 Global Meropenem Powder Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Meropenem Powder Sales Value by Region
5.1.1 Global Meropenem Powder Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Meropenem Powder Sales Value by Region (2019-2024)
5.1.3 Global Meropenem Powder Sales Value by Region (2025-2030)
5.1.4 Global Meropenem Powder Sales Value by Region (%), (2019-2030)
5.2 Global Meropenem Powder Sales Volume by Region
5.2.1 Global Meropenem Powder Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Meropenem Powder Sales Volume by Region (2019-2024)
5.2.3 Global Meropenem Powder Sales Volume by Region (2025-2030)
5.2.4 Global Meropenem Powder Sales Volume by Region (%), (2019-2030)
5.3 Global Meropenem Powder Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Meropenem Powder Sales Value, 2019-2030
5.4.2 North America Meropenem Powder Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Meropenem Powder Sales Value, 2019-2030
5.5.2 Europe Meropenem Powder Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Meropenem Powder Sales Value, 2019-2030
5.6.2 Asia Pacific Meropenem Powder Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Meropenem Powder Sales Value, 2019-2030
5.7.2 South America Meropenem Powder Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Meropenem Powder Sales Value, 2019-2030
5.8.2 Middle East & Africa Meropenem Powder Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Meropenem Powder Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Meropenem Powder Sales Value
6.2.1 Key Countries/Regions Meropenem Powder Sales Value, 2019-2030
6.2.2 Key Countries/Regions Meropenem Powder Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Meropenem Powder Sales Value, 2019-2030
6.3.2 United States Meropenem Powder Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Meropenem Powder Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Meropenem Powder Sales Value, 2019-2030
6.4.2 Europe Meropenem Powder Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Meropenem Powder Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Meropenem Powder Sales Value, 2019-2030
6.5.2 China Meropenem Powder Sales Value by Type (%), 2023 VS 2030
6.5.3 China Meropenem Powder Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Meropenem Powder Sales Value, 2019-2030
6.6.2 Japan Meropenem Powder Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Meropenem Powder Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Meropenem Powder Sales Value, 2019-2030
6.7.2 South Korea Meropenem Powder Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Meropenem Powder Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Meropenem Powder Sales Value, 2019-2030
6.8.2 Southeast Asia Meropenem Powder Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Meropenem Powder Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Meropenem Powder Sales Value, 2019-2030
6.9.2 India Meropenem Powder Sales Value by Type (%), 2023 VS 2030
6.9.3 India Meropenem Powder Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Pfizer
7.1.1 Pfizer Company Information
7.1.2 Pfizer Introduction and Business Overview
7.1.3 Pfizer Meropenem Powder Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Pfizer Meropenem Powder Product Offerings
7.1.5 Pfizer Recent Development
7.2 AuroMedics
7.2.1 AuroMedics Company Information
7.2.2 AuroMedics Introduction and Business Overview
7.2.3 AuroMedics Meropenem Powder Sales, Revenue and Gross Margin (2019-2024)
7.2.4 AuroMedics Meropenem Powder Product Offerings
7.2.5 AuroMedics Recent Development
7.3 Sandoz
7.3.1 Sandoz Company Information
7.3.2 Sandoz Introduction and Business Overview
7.3.3 Sandoz Meropenem Powder Sales, Revenue and Gross Margin (2019-2024)
7.3.4 Sandoz Meropenem Powder Product Offerings
7.3.5 Sandoz Recent Development
7.4 Amneal Pharmaceuticals
7.4.1 Amneal Pharmaceuticals Company Information
7.4.2 Amneal Pharmaceuticals Introduction and Business Overview
7.4.3 Amneal Pharmaceuticals Meropenem Powder Sales, Revenue and Gross Margin (2019-2024)
7.4.4 Amneal Pharmaceuticals Meropenem Powder Product Offerings
7.4.5 Amneal Pharmaceuticals Recent Development
7.5 Sumitomo Dainippon Pharma
7.5.1 Sumitomo Dainippon Pharma Company Information
7.5.2 Sumitomo Dainippon Pharma Introduction and Business Overview
7.5.3 Sumitomo Dainippon Pharma Meropenem Powder Sales, Revenue and Gross Margin (2019-2024)
7.5.4 Sumitomo Dainippon Pharma Meropenem Powder Product Offerings
7.5.5 Sumitomo Dainippon Pharma Recent Development
7.6 Ranbaxy Laboratories
7.6.1 Ranbaxy Laboratories Company Information
7.6.2 Ranbaxy Laboratories Introduction and Business Overview
7.6.3 Ranbaxy Laboratories Meropenem Powder Sales, Revenue and Gross Margin (2019-2024)
7.6.4 Ranbaxy Laboratories Meropenem Powder Product Offerings
7.6.5 Ranbaxy Laboratories Recent Development
7.7 Mylan
7.7.1 Mylan Company Information
7.7.2 Mylan Introduction and Business Overview
7.7.3 Mylan Meropenem Powder Sales, Revenue and Gross Margin (2019-2024)
7.7.4 Mylan Meropenem Powder Product Offerings
7.7.5 Mylan Recent Development
7.8 Sagent Pharmaceuticals
7.8.1 Sagent Pharmaceuticals Company Information
7.8.2 Sagent Pharmaceuticals Introduction and Business Overview
7.8.3 Sagent Pharmaceuticals Meropenem Powder Sales, Revenue and Gross Margin (2019-2024)
7.8.4 Sagent Pharmaceuticals Meropenem Powder Product Offerings
7.8.5 Sagent Pharmaceuticals Recent Development
7.9 Macleods Pharmaceuticals
7.9.1 Macleods Pharmaceuticals Company Information
7.9.2 Macleods Pharmaceuticals Introduction and Business Overview
7.9.3 Macleods Pharmaceuticals Meropenem Powder Sales, Revenue and Gross Margin (2019-2024)
7.9.4 Macleods Pharmaceuticals Meropenem Powder Product Offerings
7.9.5 Macleods Pharmaceuticals Recent Development
7.10 Shenzhen Haibin Pharmaceutical
7.10.1 Shenzhen Haibin Pharmaceutical Company Information
7.10.2 Shenzhen Haibin Pharmaceutical Introduction and Business Overview
7.10.3 Shenzhen Haibin Pharmaceutical Meropenem Powder Sales, Revenue and Gross Margin (2019-2024)
7.10.4 Shenzhen Haibin Pharmaceutical Meropenem Powder Product Offerings
7.10.5 Shenzhen Haibin Pharmaceutical Recent Development
7.11 Chongqing Tiandi Pharmaceutical
7.11.1 Chongqing Tiandi Pharmaceutical Company Information
7.11.2 Chongqing Tiandi Pharmaceutical Introduction and Business Overview
7.11.3 Chongqing Tiandi Pharmaceutical Meropenem Powder Sales, Revenue and Gross Margin (2019-2024)
7.11.4 Chongqing Tiandi Pharmaceutical Meropenem Powder Product Offerings
7.11.5 Chongqing Tiandi Pharmaceutical Recent Development
7.12 PKU HealthCare
7.12.1 PKU HealthCare Company Information
7.12.2 PKU HealthCare Introduction and Business Overview
7.12.3 PKU HealthCare Meropenem Powder Sales, Revenue and Gross Margin (2019-2024)
7.12.4 PKU HealthCare Meropenem Powder Product Offerings
7.12.5 PKU HealthCare Recent Development
7.13 United Laboratories
7.13.1 United Laboratories Company Information
7.13.2 United Laboratories Introduction and Business Overview
7.13.3 United Laboratories Meropenem Powder Sales, Revenue and Gross Margin (2019-2024)
7.13.4 United Laboratories Meropenem Powder Product Offerings
7.13.5 United Laboratories Recent Development
7.14 CSPC Group
7.14.1 CSPC Group Company Information
7.14.2 CSPC Group Introduction and Business Overview
7.14.3 CSPC Group Meropenem Powder Sales, Revenue and Gross Margin (2019-2024)
7.14.4 CSPC Group Meropenem Powder Product Offerings
7.14.5 CSPC Group Recent Development
7.15 Zhejiang Hisun Pharmaceutical
7.15.1 Zhejiang Hisun Pharmaceutical Company Information
7.15.2 Zhejiang Hisun Pharmaceutical Introduction and Business Overview
7.15.3 Zhejiang Hisun Pharmaceutical Meropenem Powder Sales, Revenue and Gross Margin (2019-2024)
7.15.4 Zhejiang Hisun Pharmaceutical Meropenem Powder Product Offerings
7.15.5 Zhejiang Hisun Pharmaceutical Recent Development
7.16 Luoxin Pharmaceutical
7.16.1 Luoxin Pharmaceutical Company Information
7.16.2 Luoxin Pharmaceutical Introduction and Business Overview
7.16.3 Luoxin Pharmaceutical Meropenem Powder Sales, Revenue and Gross Margin (2019-2024)
7.16.4 Luoxin Pharmaceutical Meropenem Powder Product Offerings
7.16.5 Luoxin Pharmaceutical Recent Development
8 Industry Chain Analysis
8.1 Meropenem Powder Industrial Chain
8.2 Meropenem Powder Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Meropenem Powder Sales Model
8.5.2 Sales Channel
8.5.3 Meropenem Powder Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
Table 1. Meropenem Powder Market Trends
Table 2. Meropenem Powder Market Drivers & Opportunity
Table 3. Meropenem Powder Market Challenges
Table 4. Meropenem Powder Market Restraints
Table 5. Global Meropenem Powder Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Meropenem Powder Revenue Market Share by Company (2019-2024)
Table 7. Global Meropenem Powder Sales Volume by Company (2019-2024) & (Ton)
Table 8. Global Meropenem Powder Sales Volume Market Share by Company (2019-2024)
Table 9. Global Market Meropenem Powder Price by Company (2019-2024) & (US$/Kg)
Table 10. Key Manufacturers Meropenem Powder Manufacturing Base Distribution and Headquarters
Table 11. Key Manufacturers Meropenem Powder Product Type
Table 12. Key Manufacturers Time to Begin Mass Production of Meropenem Powder
Table 13. Global Meropenem Powder Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Meropenem Powder as of 2023)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Global Meropenem Powder Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 17. Global Meropenem Powder Sales Value by Type (2019-2024) & (US$ Million)
Table 18. Global Meropenem Powder Sales Value by Type (2025-2030) & (US$ Million)
Table 19. Global Meropenem Powder Sales Market Share in Value by Type (2019-2024) & (%)
Table 20. Global Meropenem Powder Sales Market Share in Value by Type (2025-2030) & (%)
Table 21. Global Meropenem Powder Sales Volume by Type: 2019 VS 2023 VS 2030 (Ton)
Table 22. Global Meropenem Powder Sales Volume by Type (2019-2024) & (Ton)
Table 23. Global Meropenem Powder Sales Volume by Type (2025-2030) & (Ton)
Table 24. Global Meropenem Powder Sales Market Share in Volume by Type (2019-2024) & (%)
Table 25. Global Meropenem Powder Sales Market Share in Volume by Type (2025-2030) & (%)
Table 26. Global Meropenem Powder Price by Type (2019-2024) & (US$/Kg)
Table 27. Global Meropenem Powder Price by Type (2025-2030) & (US$/Kg)
Table 28. Global Meropenem Powder Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 29. Global Meropenem Powder Sales Value by Application (2019-2024) & (US$ Million)
Table 30. Global Meropenem Powder Sales Value by Application (2025-2030) & (US$ Million)
Table 31. Global Meropenem Powder Sales Market Share in Value by Application (2019-2024) & (%)
Table 32. Global Meropenem Powder Sales Market Share in Value by Application (2025-2030) & (%)
Table 33. Global Meropenem Powder Sales Volume by Application: 2019 VS 2023 VS 2030 (Ton)
Table 34. Global Meropenem Powder Sales Volume by Application (2019-2024) & (Ton)
Table 35. Global Meropenem Powder Sales Volume by Application (2025-2030) & (Ton)
Table 36. Global Meropenem Powder Sales Market Share in Volume by Application (2019-2024) & (%)
Table 37. Global Meropenem Powder Sales Market Share in Volume by Application (2025-2030) & (%)
Table 38. Global Meropenem Powder Price by Application (2019-2024) & (US$/Kg)
Table 39. Global Meropenem Powder Price by Application (2025-2030) & (US$/Kg)
Table 40. Global Meropenem Powder Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Global Meropenem Powder Sales Value by Region (2019-2024) & (US$ Million)
Table 42. Global Meropenem Powder Sales Value by Region (2025-2030) & (US$ Million)
Table 43. Global Meropenem Powder Sales Value by Region (2019-2024) & (%)
Table 44. Global Meropenem Powder Sales Value by Region (2025-2030) & (%)
Table 45. Global Meropenem Powder Sales Volume by Region (Ton): 2019 VS 2023 VS 2030
Table 46. Global Meropenem Powder Sales Volume by Region (2019-2024) & (Ton)
Table 47. Global Meropenem Powder Sales Volume by Region (2025-2030) & (Ton)
Table 48. Global Meropenem Powder Sales Volume by Region (2019-2024) & (%)
Table 49. Global Meropenem Powder Sales Volume by Region (2025-2030) & (%)
Table 50. Global Meropenem Powder Average Price by Region (2019-2024) & (US$/Kg)
Table 51. Global Meropenem Powder Average Price by Region (2025-2030) & (US$/Kg)
Table 52. Key Countries/Regions Meropenem Powder Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 53. Key Countries/Regions Meropenem Powder Sales Value, (2019-2024) & (US$ Million)
Table 54. Key Countries/Regions Meropenem Powder Sales Value, (2025-2030) & (US$ Million)
Table 55. Key Countries/Regions Meropenem Powder Sales Volume, (2019-2024) & (Ton)
Table 56. Key Countries/Regions Meropenem Powder Sales Volume, (2025-2030) & (Ton)
Table 57. Pfizer Company Information
Table 58. Pfizer Introduction and Business Overview
Table 59. Pfizer Meropenem Powder Sales (Ton), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 60. Pfizer Meropenem Powder Product Offerings
Table 61. Pfizer Recent Development
Table 62. AuroMedics Company Information
Table 63. AuroMedics Introduction and Business Overview
Table 64. AuroMedics Meropenem Powder Sales (Ton), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 65. AuroMedics Meropenem Powder Product Offerings
Table 66. AuroMedics Recent Development
Table 67. Sandoz Company Information
Table 68. Sandoz Introduction and Business Overview
Table 69. Sandoz Meropenem Powder Sales (Ton), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 70. Sandoz Meropenem Powder Product Offerings
Table 71. Sandoz Recent Development
Table 72. Amneal Pharmaceuticals Company Information
Table 73. Amneal Pharmaceuticals Introduction and Business Overview
Table 74. Amneal Pharmaceuticals Meropenem Powder Sales (Ton), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 75. Amneal Pharmaceuticals Meropenem Powder Product Offerings
Table 76. Amneal Pharmaceuticals Recent Development
Table 77. Sumitomo Dainippon Pharma Company Information
Table 78. Sumitomo Dainippon Pharma Introduction and Business Overview
Table 79. Sumitomo Dainippon Pharma Meropenem Powder Sales (Ton), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 80. Sumitomo Dainippon Pharma Meropenem Powder Product Offerings
Table 81. Sumitomo Dainippon Pharma Recent Development
Table 82. Ranbaxy Laboratories Company Information
Table 83. Ranbaxy Laboratories Introduction and Business Overview
Table 84. Ranbaxy Laboratories Meropenem Powder Sales (Ton), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 85. Ranbaxy Laboratories Meropenem Powder Product Offerings
Table 86. Ranbaxy Laboratories Recent Development
Table 87. Mylan Company Information
Table 88. Mylan Introduction and Business Overview
Table 89. Mylan Meropenem Powder Sales (Ton), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 90. Mylan Meropenem Powder Product Offerings
Table 91. Mylan Recent Development
Table 92. Sagent Pharmaceuticals Company Information
Table 93. Sagent Pharmaceuticals Introduction and Business Overview
Table 94. Sagent Pharmaceuticals Meropenem Powder Sales (Ton), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 95. Sagent Pharmaceuticals Meropenem Powder Product Offerings
Table 96. Sagent Pharmaceuticals Recent Development
Table 97. Macleods Pharmaceuticals Company Information
Table 98. Macleods Pharmaceuticals Introduction and Business Overview
Table 99. Macleods Pharmaceuticals Meropenem Powder Sales (Ton), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 100. Macleods Pharmaceuticals Meropenem Powder Product Offerings
Table 101. Macleods Pharmaceuticals Recent Development
Table 102. Shenzhen Haibin Pharmaceutical Company Information
Table 103. Shenzhen Haibin Pharmaceutical Introduction and Business Overview
Table 104. Shenzhen Haibin Pharmaceutical Meropenem Powder Sales (Ton), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 105. Shenzhen Haibin Pharmaceutical Meropenem Powder Product Offerings
Table 106. Shenzhen Haibin Pharmaceutical Recent Development
Table 107. Chongqing Tiandi Pharmaceutical Company Information
Table 108. Chongqing Tiandi Pharmaceutical Introduction and Business Overview
Table 109. Chongqing Tiandi Pharmaceutical Meropenem Powder Sales (Ton), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 110. Chongqing Tiandi Pharmaceutical Meropenem Powder Product Offerings
Table 111. Chongqing Tiandi Pharmaceutical Recent Development
Table 112. PKU HealthCare Company Information
Table 113. PKU HealthCare Introduction and Business Overview
Table 114. PKU HealthCare Meropenem Powder Sales (Ton), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 115. PKU HealthCare Meropenem Powder Product Offerings
Table 116. PKU HealthCare Recent Development
Table 117. United Laboratories Company Information
Table 118. United Laboratories Introduction and Business Overview
Table 119. United Laboratories Meropenem Powder Sales (Ton), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 120. United Laboratories Meropenem Powder Product Offerings
Table 121. United Laboratories Recent Development
Table 122. CSPC Group Company Information
Table 123. CSPC Group Introduction and Business Overview
Table 124. CSPC Group Meropenem Powder Sales (Ton), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 125. CSPC Group Meropenem Powder Product Offerings
Table 126. CSPC Group Recent Development
Table 127. Zhejiang Hisun Pharmaceutical Company Information
Table 128. Zhejiang Hisun Pharmaceutical Introduction and Business Overview
Table 129. Zhejiang Hisun Pharmaceutical Meropenem Powder Sales (Ton), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 130. Zhejiang Hisun Pharmaceutical Meropenem Powder Product Offerings
Table 131. Zhejiang Hisun Pharmaceutical Recent Development
Table 132. Luoxin Pharmaceutical Company Information
Table 133. Luoxin Pharmaceutical Introduction and Business Overview
Table 134. Luoxin Pharmaceutical Meropenem Powder Sales (Ton), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 135. Luoxin Pharmaceutical Meropenem Powder Product Offerings
Table 136. Luoxin Pharmaceutical Recent Development
Table 137. Key Raw Materials Lists
Table 138. Raw Materials Key Suppliers Lists
Table 139. Meropenem Powder Downstream Customers
Table 140. Meropenem Powder Distributors List
Table 141. Research Programs/Design for This Report
Table 142. Key Data Information from Secondary Sources
Table 143. Key Data Information from Primary Sources
List of Figures
Figure 1. Meropenem Powder Product Picture
Figure 2. Global Meropenem Powder Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Meropenem Powder Sales Value (2019-2030) & (US$ Million)
Figure 4. Global Meropenem Powder Sales Volume (2019-2030) & (Ton)
Figure 5. Global Meropenem Powder Sales Price (2019-2030) & (US$/Kg)
Figure 6. Meropenem Powder Report Years Considered
Figure 7. Global Meropenem Powder Players Revenue Ranking (2023) & (US$ Million)
Figure 8. Global Meropenem Powder Players Sales Volume Ranking (2023) & (Ton)
Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Meropenem Powder Revenue in 2023
Figure 10. Meropenem Powder Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 11. Purity Greater than or Equal to 98% Picture
Figure 12. Purity Greater than or Equal to 99% Picture
Figure 13. Global Meropenem Powder Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 14. Global Meropenem Powder Sales Value Market Share by Type, 2023 & 2030
Figure 15. Global Meropenem Powder Sales Volume by Type (2019 VS 2023 VS 2030) & (Ton)
Figure 16. Global Meropenem Powder Sales Volume Market Share by Type, 2023 & 2030
Figure 17. Global Meropenem Powder Price by Type (2019-2030) & (US$/Kg)
Figure 18. Product Picture of Skin Infection
Figure 19. Product Picture of Bacterial Meningitis
Figure 20. Product Picture of Pneumonia
Figure 21. Product Picture of Others
Figure 22. Global Meropenem Powder Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 23. Global Meropenem Powder Sales Value Market Share by Application, 2023 & 2030
Figure 24. Global Meropenem Powder Sales Volume by Application (2019 VS 2023 VS 2030) & (Ton)
Figure 25. Global Meropenem Powder Sales Volume Market Share by Application, 2023 & 2030
Figure 26. Global Meropenem Powder Price by Application (2019-2030) & (US$/Kg)
Figure 27. North America Meropenem Powder Sales Value (2019-2030) & (US$ Million)
Figure 28. North America Meropenem Powder Sales Value by Country (%), 2023 VS 2030
Figure 29. Europe Meropenem Powder Sales Value (2019-2030) & (US$ Million)
Figure 30. Europe Meropenem Powder Sales Value by Country (%), 2023 VS 2030
Figure 31. Asia Pacific Meropenem Powder Sales Value (2019-2030) & (US$ Million)
Figure 32. Asia Pacific Meropenem Powder Sales Value by Country (%), 2023 VS 2030
Figure 33. South America Meropenem Powder Sales Value (2019-2030) & (US$ Million)
Figure 34. South America Meropenem Powder Sales Value by Country (%), 2023 VS 2030
Figure 35. Middle East & Africa Meropenem Powder Sales Value (2019-2030) & (US$ Million)
Figure 36. Middle East & Africa Meropenem Powder Sales Value by Country (%), 2023 VS 2030
Figure 37. Key Countries/Regions Meropenem Powder Sales Value (%), (2019-2030)
Figure 38. Key Countries/Regions Meropenem Powder Sales Volume (%), (2019-2030)
Figure 39. United States Meropenem Powder Sales Value, (2019-2030) & (US$ Million)
Figure 40. United States Meropenem Powder Sales Value by Type (%), 2023 VS 2030
Figure 41. United States Meropenem Powder Sales Value by Application (%), 2023 VS 2030
Figure 42. Europe Meropenem Powder Sales Value, (2019-2030) & (US$ Million)
Figure 43. Europe Meropenem Powder Sales Value by Type (%), 2023 VS 2030
Figure 44. Europe Meropenem Powder Sales Value by Application (%), 2023 VS 2030
Figure 45. China Meropenem Powder Sales Value, (2019-2030) & (US$ Million)
Figure 46. China Meropenem Powder Sales Value by Type (%), 2023 VS 2030
Figure 47. China Meropenem Powder Sales Value by Application (%), 2023 VS 2030
Figure 48. Japan Meropenem Powder Sales Value, (2019-2030) & (US$ Million)
Figure 49. Japan Meropenem Powder Sales Value by Type (%), 2023 VS 2030
Figure 50. Japan Meropenem Powder Sales Value by Application (%), 2023 VS 2030
Figure 51. South Korea Meropenem Powder Sales Value, (2019-2030) & (US$ Million)
Figure 52. South Korea Meropenem Powder Sales Value by Type (%), 2023 VS 2030
Figure 53. South Korea Meropenem Powder Sales Value by Application (%), 2023 VS 2030
Figure 54. Southeast Asia Meropenem Powder Sales Value, (2019-2030) & (US$ Million)
Figure 55. Southeast Asia Meropenem Powder Sales Value by Type (%), 2023 VS 2030
Figure 56. Southeast Asia Meropenem Powder Sales Value by Application (%), 2023 VS 2030
Figure 57. India Meropenem Powder Sales Value, (2019-2030) & (US$ Million)
Figure 58. India Meropenem Powder Sales Value by Type (%), 2023 VS 2030
Figure 59. India Meropenem Powder Sales Value by Application (%), 2023 VS 2030
Figure 60. Meropenem Powder Industrial Chain
Figure 61. Meropenem Powder Manufacturing Cost Structure
Figure 62. Channels of Distribution (Direct Sales, and Distribution)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed